Annals of Family Medicine
NOVEMBER 20, 2024
This scoping review aims to systematically map non-pharmacological interventions for managing comorbid hypertension and depression, providing insights into current practices and guiding future research.
The Health Policy Exchange
FEBRUARY 12, 2013
In an Op-Ed about his nascent reform plan that appeared in the Boston Globe in November 2004, Governor Romney proposed applying "carrots and sticks" to persons who could afford private health insurance but had chosen not to purchase it. Governor Mitt Romney signs the Massachusetts health reform bill as Ted Kennedy looks on.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
SEPTEMBER 23, 2024
FDA responded to the Citizen Petitions on February 27, 2004, and issued a Press Release on March 2, 2004 (yeah, we saved that as well) concerning the PIV List. On October 4, 2000, a second Citizen Petition (FDA Legacy Docket No. 2000P-1556) was submitted by Hyman, Phelps & McNamara, P.C.,
AMMD
FEBRUARY 14, 2025
Some healthcare providers may recommend an MRI or ultrasound. Datar uses cutting-edge technology to provide noninvasive, personalized treatment options. It also provides integrative solutions that target suspicious cells. Although the founder started the company in 2004, it lacks credibility in the US.
FDA Law Blog
DECEMBER 8, 2022
In addition to providing additional examples of tree nuts, the draft guidance states that FDA considers the following categories of fish to be major food allergens under Section 201(qq): Jawless fish (e.g., 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., 1, 2023, sesame. trout); and.
FDA Law Blog
MAY 7, 2025
The Seventh Circuit took a more lenient approach than the Fourth Circuit, focusing its rationale on whether an independent contractor had improper influence over a healthcare providers independent healthcare decisions. Sorenson follows the Fifth Circuits decision last year in United States v. Marchetti, 96 F.4th Marchetti, 96 F.4th
FDA Law Blog
AUGUST 4, 2023
Because anabolic steroids are also abused to enhance athletic performance and increase muscle strength, Congress has enacted three laws regulating anabolic steroids: the Anabolic Steroid Control Acts of 1990 and 2004, and the Designer Anabolic Steroid Control Act of 2014 (“DASCA”). 50,036 (Aug.
Expert insights. Personalized for you.
130 
Let's personalize your content